Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06668558
Title Venetoclax + Azacitidine in Patients with Acute Myeloid Leukemia (VERDI)
Acronym VERDI
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP


No variant requirements are available.